Extensive transmission of SARS-CoV-2 BQ.1* variant in a population with high levels of hybrid immunity: A prevalence survey

Juan P Aguilar Ticona,Meng Xiao,Dan Li,Nivison Nery,Matt Hitchings,Emilia M M Andrade Belitardo,Mariam O Fofana,Renato Victoriano,Jaqueline S Cruz,Laise Eduarda Paixão de Moraes,Icaro Morais Strobel,Jessica Jesus Silva,Ananias Sena do Aragão Filho,Guilherme S Ribeiro,Mitermayer G Reis,Federico Costa,Ricardo Khouri,Albert I Ko,Derek A T Cummings,Juan P. Aguilar Ticona,Emilia M. M. Andrade Belitardo,Mariam O. Fofana,Jaqueline S. Cruz,Guilherme S. Ribeiro,Mitermayer G. Reis,Albert I. Ko,Derek A.T. Cummings
DOI: https://doi.org/10.1016/j.ijid.2023.11.039
IF: 12.073
2023-12-09
International Journal of Infectious Diseases
Abstract:Background The SARS-CoV-2 BQ.1* variant rapidly spread globally in late 2022, posing a challenge due to its increased immune evasion. Methods We conducted a prevalence survey in Brazil from November 16th to December 22nd, 2022, as part of a cohort study. We conducted interviews and collected nasal samples for RT-PCR testing and whole-genome sequencing. Cumulative incidence was estimated using RT-PCR positivity, cycle threshold values, and external data on the dynamics of RT-PCR positivity following infection. Results Among 535 participants, 54% had documented SARS-CoV-2 exposure before this outbreak and 74% had received COVID-19 vaccination. In this study, 14.8% tested positive for SARS-CoV-2, with BQ.1* identified in 90.7% of cases. Using case data and cycle threshold values, cumulative incidence was estimated at 56% (95%CI, 36-88%). Of the 79 positive participants, 48.1% had a symptomatic illness, with a lower proportion fulfilling the WHO COVID-19 case definition compared to prior Omicron waves. No participants required medical attention. Conclusion Despite high population-level hybrid immunity, the BQ.1* variant attacked 56% of our population. Lower disease severity was associated with BQ.1* compared to prior Omicron variants. Hybrid immunity may provide protection against future SARS-CoV-2 variants but in this case was not able to prevent widespread transmission.
infectious diseases
What problem does this paper attempt to address?